Showing results (11-20 of 19) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
The Journal of Infectious Diseases|June 25, 2016
Pre-exposure Prophylaxis With OspA-Specific Human Monoclonal Antibodies Protects Mice Against Tick Transmission of Lyme Disease SpirochetesYang Wang, Aurélie Kern, Naomi K Boatright, et al.Journal of Virology|September 18, 2009
Identification and characterization of broadly neutralizing human monoclonal antibodies directed against the E2 envelope glycoprotein of hepatitis C virusTeresa J Broering, Kerry A Garrity, Naomi K Boatright, et al.The Journal of Infectious Diseases|February 3, 2006
Therapy with a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody reduces disease severity and viral burden in golden Syrian hamstersAnjeanette Roberts, William D Thomas, Jeannette Guarner, et al.Infection and Immunity|June 6, 2018
Identification and Characterization of Human Monoclonal Antibodies for Immunoprophylaxis against Enterotoxigenic Escherichia coli InfectionSerena Giuntini, Matteo Stoppato, Maja Sedic, et al.Infection and Immunity|September 13, 2006
Human monoclonal antibodies directed against toxins A and B prevent Clostridium difficile-induced mortality in hamstersGregory J Babcock, Teresa J Broering, Hector J Hernandez, et al.Vaccine|January 24, 2007
Identification and characterization of a human monoclonal antibody that potently neutralizes a broad panel of rabies virus isolatesSusan E Sloan, Cathleen Hanlon, William Weldon, et al.The New England Journal of Medicine|January 22, 2010
Treatment with monoclonal antibodies against Clostridium difficile toxinsIsrael Lowy, Deborah C Molrine, Brett A Leav, et al.The Journal of Infectious Diseases|January 19, 2005
Development and characterization of a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody that provides effective immunoprophylaxis in miceThomas C Greenough, Gregory J Babcock, Anjeanette Roberts, et al.Proceedings of the National Academy of Sciences of the United States of America|October 22, 2004
CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirusScott A Jeffers, Sonia M Tusell, Laura Gillim-Ross, et al.Pageof 2